🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lung Disease

Ablation of Consecutive Atrial Tachycardia NCT05239364NA6 sites📍 Hamburg📍 Düsseldorf📍 Berlin Evangelical Hospital Düsseldorf · Tests: Catheter ablation Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients NCT03803787Phase 22 sites📍 Mexico City📍 Mexico City Instituto Nacional de Cancerologia de Mexico · Tests: Inhaled budesonide Validation of the French Version of the QASCI in Caregivers of Patients With COPD NCT06652204n/a2 sites📍 Brest📍 Morlaix University Hospital, Brest · Tests: questionnaire Novel Tools to Improve Management of Paediatric Community-Acquired Pneumonia - ToolCAP NCT06670833NA9 sites📍 Dakar📍 Dakar📍 Dakar Ecole Polytechnique Fédérale de Lausanne · Tests: Lung ultrasound, Standard of Care (SOC) The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy. NCT06019455n/a1 site📍 Guangzhou Sun Yat-sen University Effect of Combined Endurance Training on ADL and Walking in COPD Patients NCT05708443NA3 sites📍 Lumezzane📍 Montescano📍 Tradate Istituti Clinici Scientifici Maugeri SpA · Tests: LL group, L+UL group Assessing Pulmonary Changes in HSCT NCT07823036Phase 1, Phase 21 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Hyperpolarized 129 Xenon Metabolomics in the Diagnosis and Treatment of Asthma in Children NCT07280364n/a1 site📍 Moscow I.M. Sechenov First Moscow State Medical University · Tests: Standart medical treatment Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial) NCT07073365Phase 21 site📍 Busan Pusan National University Hospital · Tests: Local Therapy (Surgery or Radiotherapy) Hospital at Home for Elderly Acute Ill Patients NCT05360914NA3 sites📍 Silkeborg📍 Skive📍 Viborg Defactum, Central Denmark Region · Tests: Hospital at Home (HaH) treatment, Standard hospital admission Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC NCT06929936Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Trilaciclib combined with Docetaxel Colistin Methanesulfonate Sodium Inhalation for Prophylaxis of Ventilator-Associated Pneumonia (CIVAP): A Prospective, Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial NCT06834971NA1 site📍 Jinan Qilu Hospital of Shandong University · Tests: Colistimethate sodium (CMS) ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT) NCT06755814n/a1 site📍 Milan Societa Italiana di Pneumologia Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD NCT07045948NA1 site📍 Jette Universitair Ziekenhuis Brussel · Tests: Blood eosinophil Count VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites📍 Santa Rosa📍 Hartford📍 Washington D.C. VM Oncology, LLC · Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD) NCT07326592Phase 42 sites📍 Aalborg📍 Vejle CSL Behring · Tests: CE1226 CLEAR Model for Predicting Ventilatory Liberation in Severe COPD NCT07579052n/a1 site📍 Asyut Assiut University Pulmonary Rehabilitation in Advanced Lung Cancer Survivors NCT07104630Phase 21 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Pulmonary Rehabilitation (PR), No intervention: Usual care Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST) NCT07094711Phase 21 site📍 Charlottesville University of Virginia · Tests: Mycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine, preservative-free saline A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma NCT07309614Phase 35 sites📍 Nedlands📍 Montreal📍 Québec Université de Sherbrooke · Tests: Dupilumab Prefilled Syringe, Placebo Injection Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC NCT06497530Phase 21 site📍 Guangzhou Guangzhou Institute of Respiratory Disease · Tests: Serplulimab, Lurbinectedin, Carboplatin, Etoposide Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance NCT07783971n/a1 site📍 Chongqing 958th Army Hospital of the Chinese People's Liberation Army Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR) NCT05686434Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Osimertinib An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection Pathological Response After Neoadjuvant Treatment on NSCLC NCT05167487n/a17 sites📍 A Coruña📍 Alicante📍 Badalona Fundación GECP · Tests: Cisplatin, Carboplatin A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD) NCT07227207Phase 1, Phase 28 sites📍 Jacksonville📍 Boston📍 Rochester Tessera Therapeutics, Inc. · Tests: TSRA-196 Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor. NCT07754409n/a1 site📍 Gothenburg Göteborg University TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site📍 Hangzhou Shenzhen TargetRx Co., Ltd. · Tests: TGRX-1942 The Impact of Low Versus High Positive End-expiratory Pressure on Diaphragm Function, Ventilation Efficiency, and Lung Mechanics NCT07188038NA2 sites📍 Gothenburg📍 Gothenburg Vastra Gotaland Region · Tests: Low positive end-expiratory pressure, Medium positive end-expiratory pressure, High positive end-expiratory pressure Prediction Augmented Screening Initiative NCT06538636NA4 sites📍 Bedford📍 Boston📍 Ann Arbor VA Office of Research and Development · Tests: PCP-Facing Tools, LCS team population management tools
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy